SENSEX 77414.92 ▼ (0.25%)
BSE BANKEX 59542.38 ▲ (0.36%)

FABINO ENTERPRISES

BSE: 543444 28 Jun 2025
Healthcare
₹ 31.5
Fabino Life Sciences Limited is a company operating in the Healthcare sector, focusing on core business activities related to its industry.

FABINO ENTERPRISES - Share Price & Details

Market Cap
₹7.29
High /Low
39.0 / 22.8
Stock P/E
122.0
Book Value
₹20.0
Dividend Yield
0.0
ROCE
5.61
ROE
₹1.44
Face Value
10.0
PEG Ratio
NA
EVEBITDA
₹22.1
Debt
1.79
CMP / FCF
-11.7
Debt to equity
₹0.43
NP Ann
0.06
High price all time
49.0
Piotroski score
₹5.0
Graham Number
11.3
No. Eq. Shares
0.21
Net CF
₹0.18
Net profit
0.06
Price to book value
1.74
Interest Coverage
₹2.46
Low price all time
22.5
Industry PE
32.0
Reserves
₹2.10
Free Cash Flow
₹-0.17

Price Chart


Volume Chart


Peer Comparison

Stock Total Income Net Profit Net Sales EPS Market Cap (in Cr) P/E
LOOKS HEALTH SERVICES LIMITEDNANANANA5.11256.0
Triochem Products Ltd.,NANANANA0
FABINO ENTERPRISES LIMITEDNANANANA7.29122.0
ASHRAM ONLINE.COM LTD.NANANANA6.66
Ganga Pharmaceuticals LimitedNANANANA6.44322.0

Peer Comparison Chart


About FABINO ENTERPRISES

Fabino Life Sciences Limited has established itself in the Healthcare sector, offering a range of products and services that cater to its market. With a strong presence in its field, the company is committed to growth and innovation in the industry.


Latest News

Fabino Enterprises Limited Reports Earnings Results for the Half Year Ended September 30, 2024

(10 Jan 2025)
Fabino Enterprises Limited reported earnings results for the half year ended September 30, 2024. For the half year, the company reported sales was INR 42.51...
Read more →

Shilpa Pharma Lifesciences Limited, Received CEP from EDQM for API, Octreotide

(20 Nov 2024)
Shilpa Medicare Limited's 100% subsidiary, Shilpa Pharma Lifesciences Limited received certificate of suitability (CEP) from EDQM (European...
Read more →

7 Levels Of Wealth: What Stage Are You At In 2024 According To Grant Sabatier?

(26 Sep 2024)
In a world where financial anxieties loom, many Americans wonder just how financially secure they are.For those wondering, Grant Sabatier,...
Read more →

Zydus Lifesciences Ltd receives warning letter from USFDA for Jarod injectables manufacturing facility

(13 Sep 2024)
Zydus Lifesciences Ltd has received a Warning Letter issued by the USFDA relating to its Injectables manufacturing facility at Jarod near...
Read more →

FABINO ENTERPRISES TO CONDUCT AGM

(22 Aug 2024)
Fabino Enterprises announced that the Annual General Meeting (AGM) of the company will be held on 16 September 2024.
Read more →

USFDA completes inspection at transdermal manufacturing site of Zydus Lifesciences Ltd

(05 Aug 2024)
The USFDA conducted an inspection at the group's transdermal manufacturing site located at SEZ in Ahmedabad.
Read more →